Table 5.

Univariable and multivariable analyses of time to progression

	Univariable		Multivariable
	HR (95% CI)	p value	HR (95% CI)	p value
All patients
Non-BCG	1.0		1.0
BCG	0.38 (0.22–0.67)	0.001	0.52 (0.28–0.97)	0.038
Ex. CIS
Non-BCG	1.0		1.0
BCG	0.41 (0.23–0.72)	0.002	0.58 (0.32–1.06)	NS (0.075)
Ex CIS and concomitant CIS
Non-BCG	1.0		1.0
BCG	0.30 (0.15–0.61)	0.001	0.41 (0.20–0.86)	0.018

Multivariable analysis after stepwise selection: age, concomitant CIS, and stage

BCG Bacillus Calmette–Guérin, CI confidence interval, HR hazard ratio, CIS cancer in situ, NS non-significant